Obese patients with schizophrenia being treated with clozapine and non-psychiatric obese are often assumed to share the same physiological changes in obesity. The aim of this study was to identify ...

Established rapid-acting and long-acting insulin analogues have enabled more patients with type 1 diabetes mellitus to reach better glucose targets, with lower hypoglycaemia rates and a better quality ...

April 30, 2004 — Insulin determir offers improved glycemic contol compared with NPH insulin in people with type I diabetes, according to the results of a randomized trial published in the May issue of ...

"Building on Lilly's legacy of innovation in insulin therapy, once-weekly efsitora may offer a significant advancement for people with type 2 diabetes who need insulin by eliminating over 300 ...

This is a preview. Log in through your library . Abstract Longitudinal studies have shown a large excess of cardiovascular mortality in insulin-dependent diabetic patients (IDDM) as compared to ...

There are currently very few studies into the differences in gut microbiomes between races, despite significant differences between black and white individuals' average insulin resistance, BMI, and ...

Efsitora met the primary endpoint in both QWINT-2 and QWINT-4 with once-a-week dosing regimen for people living with type 2 diabetes Efsitora was equally safe and effective among adults naïve to ...

Some people with diabetes require insulin. They can manually administer this through several methods, such as syringes, which are available in different sizes with various-sized needles. There are ...

“Individualized care is still important in diabetes management, as it is in all cases, but simply having autism does not necessarily need to be seen by providers as a barrier to implementation of ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Adolescents with type 1 diabetes who use insulin pump ...

Nature study shows a new polymer can deliver insulin through the skin, raising hopes for a painless, needle-free diabetes treatment that performs as effectively as injections ...

Eric Moyal ’17, IBS MA’18, MS’22 — a 2024 BOLD Rising Star Award recipient — is on a mission to rein in the exorbitant cost of insulin. Currently, more than a million people in the U.S. who rely on ...